ERBB2 and cancer: Having identified ErbB2 as a protein carrier of the SLea antigen in ErbB2-overexpressing NCI-N87 cells, we aimed at dissecting the biosynthetic pathway of this cancer-relevant glycan epitope in this particular cell line, both in vitro and in silico.